General
Showing 33–48 of 1205 results
-
Article: Adjuvant and neoadjuvant chemotherapy regimens in breast cancer: summary from the BSMO breast cancer task force meeting
€3.03 Only for registered clients -
Article: Adjuvant chemotherapy of colon cancer: 3 versus 6 months
€3.03 Only for registered clients -
Article: Adjuvant endocrine therapy in pre- and perimenopausal women with breast cancer: practice guidelines
€3.03 Only for registered clients -
Article: Adjuvant olaparib significantly delays invasive and distant free disease in mutated breast cancer patients
€3.03 Only for registered clients -
Article: Adjuvant treatment for uterine cancers, a review of the current evidence
€3.03 Only for registered clients -
Article: Adjuvant treatment of stage III melanoma: a tabulated review of randomised phase III trials
€3.03 Only for registered clients -
Article: Advances in local therapy for patients with early-stage breast cancer
€3.03 Only for registered clients -
Article: Advancing breast cancer in the developing world: Challenges in Zimbabwe
€3.03 Only for registered clients -
Article: Afatinib prolongs survival of non-small cell lung cancer patients with an exon 19 deletion and delays progression in patients with squamous cell carcinoma of the lung
€3.03 Only for registered clients -
Article: Algorithms for molecular testing in solid tumours
€3.03 Only for registered clients -
Article: ALK and ROS1 positive non-small cell lung cancer: optimizing the continuum of care
€3.03 Only for registered clients -
Article: ALK-inhibitors in NSCLC: a tabulated review of randomised phase III trials
€3.03 Only for registered clients -
Article: All.Can Belgium Lung Cancer Working Group: Ready for take-off
€3.03 Only for registered clients -
Article: Amivantamab plus lazertinib as a first-line treatment for patients with -mutant advanced NSCLC
€3.03 Only for registered clients -
Article: AN EXPERT’S OPINION
€3.03 Only for registered clients -
Article: AN EXPERT’S OPINION
€3.03 Only for registered clients